Delayed APC/C activation extends the first mitosis of mouse embryos by Ajduk, Anna et al.
 
Supplementary Information 
for 
 
Delayed APC/C activation extends the first mitosis of mouse embryos 
 
Anna Ajduk, Bernhard Strauss, 
Jonathon Pines, Magdalena Zernicka-Goetz 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Video legends 
 
Supplementary Video S1 
Spatiotemporal dynamics of cyclin A2-YFP at 1- to 2-cell transition 
Time lapse recording of a representative zygote injected with cyclinA2-YFP mRNA dividing 
into 2-cell embryo. Video consists of  single plane images of YFP and bright field channels. 
Time shown in hours and minutes, counted from the timepoint of nuclear envelope 
breakdown (NEBD). 
 
Supplementary Video S2 
Spatiotemporal dynamics of cyclin B1-YFP at 1- to 2-cell transition 
Time lapse recording of a representative zygote injected with cyclinB1-YFP and histone H2B-
RFP mRNAs dividing into 2-cell embryo. Video consists of  single plane images of RFP and YFP 
channels. Time shown in hours and minutes, counted from the timepoint of nuclear 
envelope breakdown (NEBD). 
  
Supplementary Table S1 
Mitotic timings in mouse embryos injected with securin-GFP 
 
a p<0.001, b p<0.05 comparing to control embryos        
Supplementary Table S2 
Morpholinos and siRNAs used in the experiments 
 
Type of morpholino: Sequence 5’to 3’: 
Emi2 MO ATT GCT TCC TGC TCT GTG GCT GGC T 
Emi2-5MP (with 5 mismatched 
pairs of nucleotides) MO  
ATT CCT TGC TGC TGT GTG CCT GCC T 
  
Type of siRNA: Sequence 5’ to 3’: 
Emi2 siRNA GUC AAA UAA UGA AGU CUG U [dT][dT] 
ACA GAC UUC AUU AUU UGA C [dT][dT] 
 
control siRNA MISSION siRNA Universal Negative Control 1 (Sigma-
Aldrich)  
Experimental 
conditions Total no. 
Time between NEBD  
and securin degradation 
(min; median (Q1;Q3)) 
Time between NEBD 
 and anaphase    
(min; median (Q1;Q3)) 
1-
ce
ll 
control 19 36.0 (30.0 ; 40.5) 90.0 (84.0 ; 93.0) 
reversine 6 24.0 (21.8 ; 28.5)b 73.5 (72.0 ; 77.3)a 
wt Plk1 OE 19 27.0 (24.0 ; 28.5)b 75.0 (72.0 ; 81.0)a 
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Supplementary Figure S1 
SAC- and Plk1-dependent regulation of securin degradation in zygotes 
(a) Quantification of securin-GFP degradation in control zygotes and zygotes treated with reversine, averaged 
from 19 and 6 embryos respectively. (b) Quantification of securin-GFP degradation in control zygotes and 
zygotes injected with wt Plk1-TagRFP, averaged from 19 and 19 embryos respectively. Plots (a) and (b) show 
mean values +/- standard deviation.   
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Supplementary Figure S2 
MO-mediated Emi2 depletion in oocytes 
(a) Percentage of oocytes activated after injection with Emi2 MO or Emi2-5MP MO (n=36 and 21, 
respectively). (b) Cyclin B1-YFP levels in representative oocytes injected with Emi2 MO or Emi2-5MP MO.  
b 
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Supplementary Figure S3 
siRNA-mediated depletion of Emi2 in oocytes and its impact on securin degradation 
(a) Quantification of securin-GFP degradation in parthenogenotes injected with control and Emi2-specific siRNA, 
averaged from 6 and 18 embryos respectively. Plots show mean values +/- standard deviation. (b) Time between 
NEBD and the onset of securin-GFP degradation in parthenogenotes injected with control and Emi2-specific 
siRNA, averaged from 6 and 18 embryos respectively. The boxes show medians and the first and third quartiles. 
The whiskers are set at 1.5*IQR above the third and below the first quartile. Outlier values are marked with dots. 
(c) Percentage of oocytes activated after injection with control and Emi2-specific siRNA (n=8 and 34, 
respectively).  
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Supplementary Figure S4 
Effect of Plk1 inhibition on mitotic spindle assembly and maintenance in zygotes 
(a) Images of fixed zygotes stained for tubulin β (green) and chromatin (red). Arrows mark spindle poles, an 
asterisk – a chromosome dislocated from the metaphase plate, a dashed line surrounds a region enlarged in 
the far right image. (b) Effect of SAC inhibition on BI2536-induced M-phase block in zygotes. Images of fixed 
control embryos, embryos treated only with BI2536, injected with dn Mad2 and treated with BI2536, and 
treated with BI2536 and reversine stained for tubulin β (green) and chromatin (red). Scale bars 20 µm. 
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Amount and distribution of phospho-Plk1 in embryos  
(a) Levels of Plk1 phosphorylated at Thr210 (pPlk1) in M-phase zygotes and 2-cell embryos, and in 2- and 4-
cell embryos in interphase. The image shows a representative z-stack projection of fixed embryos labeled for 
pPlk1 (green) and chromatin (red). Arrow indicates a 2-cell stage blastomere in interphase. Scale bar 20 µm. 
The graph shows quantification of the mean intensity of pPlk1 immunostaining. The boxes show medians and 
the first and third quartiles. The whiskers are set at 1.5*IQR above the third and below the first quartile. Outlier 
values are marked with dots. (b) Transcriptomic data (in fragments per kilobase million) regarding expression 
of Plk1 and its known activators (the left panel), and subunits of the protein phosphatase 2A (a Plk1 inhibitor; 
the right panel). Based on the DBTMEE database (RNA-seq Ver2_FPKM collection, http://dbtmee.hgc.jp/). (c) 
pPlk1 localization on M-phase chromosomes in zygotes and 2-cell embryos. Single-plane images of fixed 
embryos stained for pPlk1 (green) and chromatin (red). Scale bar 20 µm.  
